Variant report

Variant	esv3426224
Chromosome Location	chr11:4207601-4210149
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:599)
CpG islands
(count:367)
Chromatin interactive
region (count:6)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:599 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:4208203-4208403	K562	blood:	n/a	n/a
2	ATF3	chr11:4208748-4209028	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr11:4209051-4209129	K562	blood:	n/a	n/a
4	BACH1	chr11:4208789-4209061	H1-hESC	embryonic stem cell:	n/a	n/a
5	BHLHE40	chr11:4208773-4209110	K562	blood:	n/a	chr11:4208989-4209005
6	BHLHE40	chr11:4208769-4209074	GM12878	blood:	n/a	chr11:4208989-4209005
7	BHLHE40	chr11:4208122-4208459	K562	blood:	n/a	n/a
8	BRCA1	chr11:4208855-4208989	HepG2	liver:	n/a	n/a
9	BRCA1	chr11:4208834-4209055	Hela-S3	cervix:	n/a	n/a
10	CBX3	chr11:4208772-4209129	K562	blood:	n/a	n/a
11	CBX3	chr11:4208019-4208474	K562	blood:	n/a	n/a
12	CBX3	chr11:4207969-4208291	K562	blood:	n/a	n/a
13	CCNT2	chr11:4208203-4209367	K562	blood:	n/a	chr11:4209066-4209075 chr11:4208444-4208453
14	CEBPB	chr11:4208295-4208391	K562	blood:	n/a	n/a
15	CEBPB	chr11:4208794-4209159	Hela-S3	cervix:	n/a	n/a
16	CEBPB	chr11:4208020-4208479	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr11:4208855-4209254	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr11:4208893-4208908	K562	blood:	n/a	n/a
19	CHD1	chr11:4208309-4208509	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD2	chr11:4208962-4209085	K562	blood:	n/a	n/a
21	CHD2	chr11:4209597-4209601	GM12878	blood:	n/a	n/a
22	CHD2	chr11:4208767-4209067	HepG2	liver:	n/a	n/a
23	CHD2	chr11:4208246-4208547	H1-hESC	embryonic stem cell:	n/a	n/a
24	CHD2	chr11:4208176-4208453	K562	blood:	n/a	n/a
25	CHD2	chr11:4208812-4209073	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD2	chr11:4208132-4209127	Hela-S3	cervix:	n/a	n/a
27	CREB1	chr11:4208581-4209216	H1-hESC	embryonic stem cell:	n/a	n/a
28	CREB1	chr11:4208395-4209135	A549	lung:	n/a	n/a
29	CTBP2	chr11:4208283-4209121	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr11:4208140-4208475	HepG2	liver:	n/a	n/a
31	CTCF	chr11:4208840-4208990	HEEpiC	esophagus:	n/a	chr11:4208948-4208966
32	CTCF	chr11:4208280-4208430	WERI-Rb-1	eye:	n/a	n/a
33	CTCF	chr11:4208240-4208390	GM12874	blood:	n/a	n/a
34	CTCF	chr11:4208920-4209070	NB4	blood:	n/a	chr11:4208948-4208966
35	CTCF	chr11:4208807-4209129	Lung_OC	lung:	n/a	chr11:4208948-4208966
36	CTCF	chr11:4208163-4208411	A549	lung:	n/a	n/a
37	CTCF	chr11:4208260-4208410	HPF	lung:	n/a	n/a
38	CTCF	chr11:4208194-4208513	GM13977	blood:	n/a	n/a
39	CTCF	chr11:4208201-4208398	SK-N-SH_RA	brain:	n/a	n/a
40	CTCF	chr11:4208190-4208530	K562	blood:	n/a	n/a
41	CTCF	chr11:4208280-4208430	BJ	skin:	n/a	n/a
42	CTCF	chr11:4208135-4209206	IMR90	lung:	n/a	chr11:4208948-4208966
43	CTCF	chr11:4208659-4209214	H1-hESC	embryonic stem cell:	n/a	chr11:4208948-4208966
44	CTCF	chr11:4208171-4208503	K562	blood:	n/a	n/a
45	CTCF	chr11:4208766-4209144	T-47D	breast:	n/a	chr11:4208948-4208966
46	CTCF	chr11:4208593-4208678	K562	blood:	n/a	n/a
47	CTCF	chr11:4208860-4209010	BE2_C	brain:	n/a	chr11:4208948-4208966
48	CTCF	chr11:4208280-4208430	GM12875	blood:	n/a	n/a
49	CTCF	chr11:4208880-4209030	GM12871	blood:	n/a	chr11:4208948-4208966
50	CTCF	chr11:4208788-4209094	Medullo	brain:	n/a	chr11:4208948-4208966

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:4209397-4209447	SK-N-MC	brain:	n/a
2	chr11:4209397-4209447	SK-N-MC	brain:	n/a
3	chr11:4208723-4208773	PrEC	prostate:	n/a
4	chr11:4208905-4208955	SKMC	muscle:	n/a
5	chr11:4208449-4208499	MCF10A-Er-Src	breast:	n/a
6	chr11:4208278-4208328	SK-N-SH_RA	brain:	n/a
7	chr11:4209120-4209170	ovcar-3	ovarian:	n/a
8	chr11:4209120-4209170	GM19239	blood:	n/a
9	chr11:4208723-4208773	HNPCEpiC	eye:	n/a
10	chr11:4208449-4208499	RPTEC	kidney:	n/a
11	chr11:4208278-4208328	NT2-D1	testis:	n/a
12	chr11:4208723-4208773	NHDF-neo	bronchial:	n/a
13	chr11:4209120-4209170	HIPEpiC	eye:	n/a
14	chr11:4208278-4208328	HNPCEpiC	eye:	n/a
15	chr11:4208449-4208499	Hela-S3	cervix:	n/a
16	chr11:4209120-4209170	AG09309	skin:	n/a
17	chr11:4208278-4208328	AG09319	gingival:	n/a
18	chr11:4208905-4208955	HNPCEpiC	eye:	n/a
19	chr11:4209120-4209170	HPAEpiC	pulmonary alveolar:	n/a
20	chr11:4209397-4209447	ECC-1	luminal epithelium:	n/a
21	chr11:4208278-4208328	SKMC	muscle:	n/a
22	chr11:4208449-4208499	ECC-1	luminal epithelium:	n/a
23	chr11:4209397-4209447	HPAEpiC	pulmonary alveolar:	n/a
24	chr11:4209120-4209170	U87	brain:	n/a
25	chr11:4208449-4208499	T-47D	breast:	n/a
26	chr11:4209397-4209447	HRPEpiC	eye:	n/a
27	chr11:4209120-4209170	HUVEC	blood vessel:	n/a
28	chr11:4209120-4209170	Hela-S3	cervix:	n/a
29	chr11:4208449-4208499	SKMC	muscle:	n/a
30	chr11:4208723-4208773	CMK	blood:	n/a
31	chr11:4208723-4208773	HCM	heart:	n/a
32	chr11:4208278-4208328	MCF10A-Er-Src	breast:	n/a
33	chr11:4209397-4209447	ProgFib	skin:	n/a
34	chr11:4208449-4208499	HCT-116	colon:	n/a
35	chr11:4209397-4209447	AG10803	skin:	n/a
36	chr11:4208723-4208773	MCF-7	breast:	n/a
37	chr11:4209120-4209170	GM06990	blood:	n/a
38	chr11:4209397-4209447	T-47D	breast:	n/a
39	chr11:4208723-4208773	PFSK-1	brain:	n/a
40	chr11:4209397-4209447	AoSMC	blood vessel:	n/a
41	chr11:4209397-4209447	HepG2	liver:	n/a
42	chr11:4209397-4209447	GM12878	blood:	n/a
43	chr11:4209397-4209447	LNCaP	prostate:	n/a
44	chr11:4209120-4209170	HRPEpiC	eye:	n/a
45	chr11:4209120-4209170	LNCaP	prostate:	n/a
46	chr11:4208905-4208955	U87	brain:	n/a
47	chr11:4208278-4208328	AG09309	skin:	n/a
48	chr11:4208278-4208328	SK-N-MC	brain:	n/a
49	chr11:4208723-4208773	SK-N-MC	brain:	n/a
50	chr11:4209397-4209447	U87	brain:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:4205317..4208248-chr11:4208372..4210447,2	K562	blood:
2	chr11:4205317..4208248-chr11:4208372..4210447,2	K562	blood:
3	chr11:4208647..4209327-chr11:4572350..4573087,2	MCF-7	breast:
4	chr11:4208460..4209382-chr11:4513705..4515541,8	MCF-7	breast:
5	chr11:4208515..4209433-chr11:4658248..4659042,2	K562	blood:
6	chr11:4208891..4209471-chr11:4572771..4573597,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RRM1-2	chr11:4208370-4208434	ENSG00000254480.1
2	lnc-RRM1-2	chr11:4208382-4208434	NR_047550

No data

Variant related genes	Relation type
ENSG00000254480	TF binding region
ENSG00000254480	CpG island

Extended variants
information (count: 93 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:93 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs369782787	chr11:4207608-4207609	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs11031248	chr11:4207639-4207640	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs10835726	chr11:4207650-4207651	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs568792399	chr11:4207726-4207727	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs201979376	chr11:4207730-4207731	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs535902234	chr11:4207731-4207732	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs537087165	chr11:4207764-4207765	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs554587835	chr11:4207770-4207771	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs115973620	chr11:4207782-4207783	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs11031249	chr11:4207861-4207862	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs553614487	chr11:4207941-4207942	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs575131524	chr11:4207956-4207957	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs542419627	chr11:4207969-4207970	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs563351132	chr11:4208025-4208026	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs377378444	chr11:4208036-4208037	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs576925216	chr11:4208060-4208061	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs564004980	chr11:4208111-4208112	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs11031250	chr11:4208130-4208131	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs149497996	chr11:4208159-4208160	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs564063050	chr11:4208212-4208213	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs528182392	chr11:4208262-4208263	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs546714652	chr11:4208263-4208264	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs188921969	chr11:4208269-4208270	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs181578919	chr11:4208278-4208279	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs73427012	chr11:4208302-4208303	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs144154128	chr11:4208303-4208304	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs374238079	chr11:4208342-4208343	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs552294038	chr11:4208364-4208365	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs35054066	chr11:4208376-4208377	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs186283445	chr11:4208387-4208388	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs538956441	chr11:4208407-4208408	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs570787292	chr11:4208450-4208451	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs11826292	chr11:4208464-4208465	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs139954362	chr11:4208499-4208500	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs535632546	chr11:4208528-4208529	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs568548449	chr11:4208552-4208553	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs536068315	chr11:4208582-4208583	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs557558549	chr11:4208620-4208621	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs375998067	chr11:4208630-4208631	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs143191149	chr11:4208631-4208632	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs558157035	chr11:4208672-4208673	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
42	rs71961866	chr11:4208687-4208688	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
43	rs572843465	chr11:4208692-4208693	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
44	rs56232807	chr11:4208698-4208699	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs7941367	chr11:4208771-4208772	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs561482038	chr11:4208792-4208793	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
47	rs528921763	chr11:4208833-4208834	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
48	rs544026957	chr11:4208837-4208838	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
49	rs190166119	chr11:4208863-4208864	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
50	rs146191730	chr11:4208874-4208875	Active TSS Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Neuroblastoma	18923191	CNVD
Breast cancer	19432969	CNVD
Alzheimer''s disease	17576883	CNVD
Long-qt syndrome	17576883	CNVD
Emphysema	19352772	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chordoma	18071362	CNVD
Breast cancer	16608533	CNVD
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Barrett''s syndrome	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Myelofibrosis	22110671	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Neuroblastoma	21124317	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Schizophrenia	21399695	CNVD
Gastric cancer	16891809	CNVD
Cancer	17160897	CNVD
Multiple myeloma	16616336	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
early-passage human iPS cells	21368824	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:324 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:4197600-4208200	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr11:4197600-4208200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr11:4200000-4208200	Enhancers	Liver	Liver
4	chr11:4205600-4208000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr11:4205800-4209000	Weak transcription	Fetal Lung	lung
6	chr11:4206200-4208200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr11:4206200-4208200	Weak transcription	Right Ventricle	heart
8	chr11:4206400-4208000	Weak transcription	Colon Smooth Muscle	Colon
9	chr11:4206400-4208000	Weak transcription	K562	blood
10	chr11:4206400-4208200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr11:4206800-4207800	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr11:4206800-4208200	Enhancers	Primary hematopoietic stem cells	blood
13	chr11:4206800-4209200	Weak transcription	Fetal Heart	heart
14	chr11:4207800-4208000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
15	chr11:4208000-4208200	Enhancers	Primary hematopoietic stem cells short term culture	blood
16	chr11:4208000-4208200	Enhancers	Brain Germinal Matrix	brain
17	chr11:4208000-4208200	Enhancers	Colon Smooth Muscle	Colon
18	chr11:4208000-4208200	Enhancers	HUVEC	blood vessel
19	chr11:4208000-4208400	Flanking Active TSS	Hela-S3	cervix
20	chr11:4208000-4208600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr11:4208000-4209000	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr11:4208000-4209200	Active TSS	HUES48 Cell Line	embryonic stem cell
23	chr11:4208000-4209200	Active TSS	HUES6 Cell Line	embryonic stem cell
24	chr11:4208000-4209200	Active TSS	HUES64 Cell Line	embryonic stem cell
25	chr11:4208000-4209200	Active TSS	iPS-15b Cell Line	embryonic stem cell
26	chr11:4208000-4209200	Active TSS	iPS-18 Cell Line	embryonic stem cell
27	chr11:4208000-4209200	Active TSS	iPS-20b Cell Line	embryonic stem cell
28	chr11:4208000-4209200	Active TSS	K562	blood
29	chr11:4208000-4209400	Active TSS	H1 Cell Line	embryonic stem cell
30	chr11:4208000-4209400	Active TSS	A549	lung
31	chr11:4208000-4209600	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr11:4208200-4208400	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr11:4208200-4208400	Enhancers	Primary neutrophils fromperipheralblood	blood
34	chr11:4208200-4208400	Enhancers	Primary B cells from cord blood	blood
35	chr11:4208200-4208400	Active TSS	Primary hematopoietic stem cells short term culture	blood
36	chr11:4208200-4208400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
37	chr11:4208200-4208400	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
38	chr11:4208200-4208400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr11:4208200-4208400	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
40	chr11:4208200-4208400	Active TSS	Adipose Nuclei	Adipose
41	chr11:4208200-4208400	Flanking Active TSS	Liver	Liver
42	chr11:4208200-4208400	Active TSS	Colonic Mucosa	Colon
43	chr11:4208200-4208400	Active TSS	Rectal Mucosa Donor 31	rectum
44	chr11:4208200-4208400	Active TSS	Right Ventricle	heart
45	chr11:4208200-4208400	Active TSS	Skeletal Muscle Female	skeletal muscle
46	chr11:4208200-4208400	Active TSS	GM12878-XiMat	blood
47	chr11:4208200-4208400	Active TSS	HMEC	breast
48	chr11:4208200-4208400	Active TSS	Monocytes-CD14+_RO01746	blood
49	chr11:4208200-4208600	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
50	chr11:4208200-4208600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links